These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 12601256

  • 1. Effects of direct hemoperfusion with a beta2-microglobulin adsorption column on hypercytokinemia in rats.
    Nakatani T, Tsuchida K, Fu O, Sugimura K, Takemoto Y.
    Blood Purif; 2003; 21(2):145-51. PubMed ID: 12601256
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Direct hemoperfusion by using Lixelle column for the treatment of systemic inflammatory response syndrome.
    Tsuchida K, Takemoto Y, Sugimura K, Yoshimura R, Nakatani T.
    Int J Mol Med; 2002 Oct; 10(4):485-8. PubMed ID: 12239598
    [Abstract] [Full Text] [Related]

  • 4. Comparison of a cytokine adsorbing column and an endotoxin absorbing column for the treatment of experimental endotoxemia.
    Taniguchi T, Kurita A, Yamamoto K, Inaba H.
    Transfus Apher Sci; 2009 Feb; 40(1):55-9. PubMed ID: 19103510
    [Abstract] [Full Text] [Related]

  • 5. Polymyxin B-immobilized fiber column direct hemoperfusion and continuous hemodiafiltration in premature neonates with systemic inflammatory response syndrome.
    Maede Y, Ibara S, Tokuhisa T, Ishihara C, Hirakawa E, Matsui T, Takahashi D, Machigashira S, Minakami H.
    Pediatr Int; 2016 Nov; 58(11):1176-1182. PubMed ID: 27062100
    [Abstract] [Full Text] [Related]

  • 6. A novel adsorbent of circulating bacterial toxins and cytokines: the effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia.
    Taniguchi T, Hirai F, Takemoto Y, Tsuda K, Yamamoto K, Inaba H, Sakurai H, Furuyoshi S, Tani N.
    Crit Care Med; 2006 Mar; 34(3):800-6. PubMed ID: 16521274
    [Abstract] [Full Text] [Related]

  • 7. Direct hemoperfusion with a beta2-microglobulin-selective adsorbent column eliminates inflammatory cytokines and improves pulmonary oxygenation.
    Kono K, Toda S, Hora K, Kiyosawa K.
    Ther Apher Dial; 2009 Feb; 13(1):27-33. PubMed ID: 19379167
    [Abstract] [Full Text] [Related]

  • 8. Dose-related effects of direct hemoperfusion using a cytokine adsorbent column for the treatment of experimental endotoxemia.
    Taniguchi T, Kurita A, Mukawa C, Yamamoto K, Inaba H.
    Intensive Care Med; 2007 Mar; 33(3):529-33. PubMed ID: 17160419
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of hemoperfusion using polymyxin B-immobilized fibers on non-shock rat sepsis model.
    Iba T, Okamoto K, Kawasaki S, Nakarai E, Miyasho T.
    J Surg Res; 2011 Dec; 171(2):755-61. PubMed ID: 20655065
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel immunotherapeutic modality with direct hemoperfusion targeting transforming growth factor-beta prolongs the survival of tumor-bearing rats.
    Yamamoto Y, Ueda Y, Itoh T, Iwamoto A, Yamagishi H, Shimagaki M, Teramoto K.
    Oncol Rep; 2006 Dec; 16(6):1277-84. PubMed ID: 17089050
    [Abstract] [Full Text] [Related]

  • 14. Direct hemoperfusion with a cytokine-adsorbing device for the treatment of persistent or severe hypercytokinemia: a pilot study.
    Kobe Y, Oda S, Matsuda K, Nakamura M, Hirasawa H.
    Blood Purif; 2007 Dec; 25(5-6):446-53. PubMed ID: 18037813
    [Abstract] [Full Text] [Related]

  • 15. Isoflurane inhalation after induction of endotoxemia in rats attenuates the systemic cytokine response.
    Flondor M, Hofstetter C, Boost KA, Betz C, Homann M, Zwissler B.
    Eur Surg Res; 2008 Dec; 40(1):1-6. PubMed ID: 17717418
    [Abstract] [Full Text] [Related]

  • 16. Differential induction of adrenomedullin, interleukins and tumour necrosis factor-alpha by lipopolysaccharide in rat tissues in vivo.
    Li YY, Wong LY, Cheung BM, Hwang IS, Tang F.
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1110-8. PubMed ID: 16445578
    [Abstract] [Full Text] [Related]

  • 17. Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia.
    Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, Poynter JA, Meldrum DR.
    Surgery; 2010 Aug; 148(2):444-52. PubMed ID: 20434747
    [Abstract] [Full Text] [Related]

  • 18. Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure.
    Ikeda T, Ikeda K, Nagura M, Taniuchi H, Matsushita M, Kiuchi S, Kuroki Y, Suzuki K, Matsuno N.
    Ther Apher Dial; 2004 Aug; 8(4):293-8. PubMed ID: 15274680
    [Abstract] [Full Text] [Related]

  • 19. Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle.
    Lang CH, Silvis C, Deshpande N, Nystrom G, Frost RA.
    Shock; 2003 Jun; 19(6):538-46. PubMed ID: 12785009
    [Abstract] [Full Text] [Related]

  • 20. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia.
    Lechner AJ, Velasquez A, Knudsen KR, Johanns CA, Tracy TF, Matuschak GM.
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1550-8. PubMed ID: 9603137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.